BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
BIOTRICITY INC. (BTCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations of 15.00 thousand shares for the 12-month period ending 2025-03-31, per its 10-K/A filed 2025-07-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations · last filed 2025-07-18
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for the quarter ending 2024-03-31 was 888.28K shares.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for the quarter ending 2023-12-31 was 4.46K shares, a 98.39% decline year-over-year.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for the quarter ending 2023-09-30 was -89.12K shares, a 158.74% decline year-over-year.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for fiscal 2025 was 15.00K shares, a 98.36% decline from fiscal 2024.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for fiscal 2024 was 913.62K shares, a 158.73% increase from fiscal 2023.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for fiscal 2023 was 353.12K shares, a 21.39% decline from fiscal 2022.
- BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures and expirations for fiscal 2022 was 449.17K shares, a 81.85% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 14 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 15 month |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-07-18 | 15.00K shares 10-K/A · filed 2025-07-18 | ||||||
| 2024-12-31 | 15.00K shares 10-Q/A · filed 2025-02-20 | |||||||
| 2024-03-31 | 888.28K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-07-18 | 892.74K shares derived: sum of 2 quarters · filed 2025-07-18 | 803.62K shares derived: sum of 3 quarters · filed 2025-07-18 | 913.62K shares 10-K/A · filed 2025-07-18 | ||||
| 2023-12-31 | 4.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-20 | -84.65K shares derived: sum of 2 quarters · filed 2024-02-20 | 25.35K shares 10-Q · filed 2024-02-20 | |||||
| 2023-09-30 | -89.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-14 | 20.88K shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 110.00K shares 10-Q · filed 2023-08-14 | |||||||
| 2023-03-31 | 353.12K shares 10-K · filed 2024-06-27 | 2.12M shares 10-K · filed 2023-06-29 | ||||||
| 2022-12-31 | 278.00K shares 10-Q · filed 2023-02-14 | 429.72K shares derived: sum of 2 quarters · filed 2023-02-14 | 1.99M shares derived: sum of 3 quarters · filed 2023-02-14 | |||||
| 2022-09-30 | 151.72K shares 10-Q · filed 2023-02-14 | 1.72M shares derived: sum of 2 quarters · filed 2023-02-14 | ||||||
| 2022-06-30 | 1.56M shares 10-Q · filed 2023-02-14 | |||||||
| 2022-03-31 | 449.17K shares 10-K · filed 2023-06-29 | |||||||
| 2021-12-31 | 169.50K shares 10-Q · filed 2022-02-14 | 399.09K shares derived: sum of 2 quarters · filed 2022-02-14 | 492.84K shares derived: sum of 3 quarters · filed 2022-02-14 | |||||
| 2021-09-30 | 229.58K shares 10-Q · filed 2022-02-14 | 323.33K shares derived: sum of 2 quarters · filed 2022-02-14 | ||||||
| 2021-06-30 | 93.75K shares 10-Q · filed 2022-02-14 | |||||||
| 2021-03-31 | 2.48M shares 10-K · filed 2022-07-14 | |||||||
| 2020-12-31 | 36.25K shares 10-Q · filed 2021-02-16 | 241.25K shares derived: sum of 2 quarters · filed 2021-02-16 | 2.05M shares derived: sum of 3 quarters · filed 2021-02-16 | 2.15M shares derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2020-09-30 | 205.00K shares 10-Q · filed 2021-02-16 | 2.02M shares derived: sum of 2 quarters · filed 2021-02-16 | 2.11M shares derived: sum of 3 quarters · filed 2021-02-16 | 2.15M shares derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2020-06-30 | 1.81M shares 10-Q · filed 2021-02-16 | 1.91M shares derived: sum of 2 quarters · filed 2021-02-16 | 1.94M shares derived: sum of 3 quarters · filed 2021-02-16 | 1.95M shares derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2020-03-31 | 98.75K shares 10-Q · filed 2021-02-16 | 95.75K shares 10-Q · filed 2020-08-14 | 133.75K shares derived: sum of 2 quarters · filed 2021-02-16 | 143.75K shares derived: sum of 3 quarters · filed 2021-02-16 | 148.75K shares 10-K · filed 2022-07-14 | |||
| 2019-12-31 | 35.00K shares 10-Q · filed 2021-02-16 | 45.00K shares derived: sum of 2 quarters · filed 2021-02-16 | 50.00K shares derived: sum of 3 quarters · filed 2021-02-16 | 234.92K shares derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | 10.00K shares 10-Q · filed 2021-02-16 | 15.00K shares derived: sum of 2 quarters · filed 2021-02-16 | 199.92K shares derived: sum of 3 quarters · filed 2021-02-16 | 326.17K shares derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-06-30 | 5.00K shares 10-Q · filed 2021-02-16 | 189.92K shares derived: sum of 2 quarters · filed 2021-02-16 | 316.17K shares derived: sum of 3 quarters · filed 2021-02-16 | |||||
| 2019-03-31 | 184.92K shares 10-Q · filed 2020-11-13 | 311.17K shares derived: sum of 2 quarters · filed 2020-11-13 | 342.42K shares 10-K · filed 2020-07-15 | |||||
| 2018-12-31 | 126.25K shares 10-Q · filed 2020-11-13 | |||||||
| 2018-06-30 | 31.25K shares 10-Q · filed 2020-11-13 | |||||||
| 2018-03-31 | 400.24K shares 10-K · filed 2020-07-15 | |||||||
| 2017-03-31 | 285.28K shares 10-K · filed 2019-07-16 | 285.28K shares 10-K · filed 2020-07-15 |